glp-1 drugs pcos for PCOS: Is It the Right Choice? Superior metabolic improvement of polycystic
Description
J Neurosci (2017) 37(48):1170114
Moreover, these drugs promote the neogenesis of pancreatic cells by enhancing B cell proliferation and reducing apoptosis, contributing to the preservation and expansion of insulin-secreting cells (54)
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
Patient Type Analysis The anti-obesity drugs market is predominantly driven by adult patients contributing 95.3% share in 2024, reflecting the high prevalence of obesity in this demographic
